These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3620488)

  • 1. The subcellular localization of phytanic acid oxidase in rat liver.
    Skjeldal OH; Stokke O
    Biochim Biophys Acta; 1987 Sep; 921(1):38-42. PubMed ID: 3620488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disorders related to the metabolism of phytanic acid.
    Stokke O; Skjeldal OH; Høie K
    Scand J Clin Lab Invest Suppl; 1986; 184():3-10. PubMed ID: 2438746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biochemical heterogeneity in conditions with phytanic acid accumulation.
    Skjeldal OH; Stokke O; Refsum S; Norseth J; Petit H
    J Neurol Sci; 1987 Jan; 77(1):87-96. PubMed ID: 2433405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytanic acid oxidase activity in cultured skin fibroblasts. Diagnostic usefulness and limitations.
    Skjeldal OH; Stokke O; Norseth J; Lie SO
    Scand J Clin Lab Invest; 1986 May; 46(3):283-7. PubMed ID: 2424078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders.
    Poll-The BT; Skjeldal OH; Stokke O; Poulos A; Demaugre F; Saudubray JM
    Hum Genet; 1989 Jan; 81(2):175-81. PubMed ID: 2463966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial oxidation of phytanic acid in human and monkey liver: implication that Refsum's disease is not a peroxisomal disorder.
    Watkins PA; Mihalik SJ
    Biochem Biophys Res Commun; 1990 Mar; 167(2):580-6. PubMed ID: 1690986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infantile Refsum's disease (phytanic acid storage disease): a variant of Zellweger's syndrome?
    Poulos A; Sharp P; Whiting M
    Clin Genet; 1984 Dec; 26(6):579-86. PubMed ID: 6209040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence against alpha-hydroxyphytanic acid as an intermediate in the metabolism of phytanic acid.
    Skjeldal OH; Stokke O
    Scand J Clin Lab Invest; 1988 Feb; 48(1):97-102. PubMed ID: 2464193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phytanic acid must be activated to phytanoyl-CoA prior to its alpha-oxidation in rat liver peroxisomes.
    Watkins PA; Howard AE; Mihalik SJ
    Biochim Biophys Acta; 1994 Oct; 1214(3):288-94. PubMed ID: 7918611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phytanic acid alpha-oxidation in rat liver peroxisomes. Production of alpha-hydroxyphytanoyl-CoA and formate is enhanced by dioxygenase cofactors.
    Mihalik SJ; Rainville AM; Watkins PA
    Eur J Biochem; 1995 Sep; 232(2):545-51. PubMed ID: 7556205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebro-hepato-renal (Zellweger) syndrome, adrenoleukodystrophy, and Refsum's disease: plasma changes and skin fibroblast phytanic acid oxidase.
    Poulos A; Sharp P; Fellenberg AJ; Danks DM
    Hum Genet; 1985; 70(2):172-7. PubMed ID: 2408988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
    Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
    J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytanic acid and very long chain fatty acids in genetic peroxisomal disorders.
    Molzer B; Kainz-Korschinsky M; Sundt-Heller R; Bernheimer H
    J Clin Chem Clin Biochem; 1989 May; 27(5):309-14. PubMed ID: 2474624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refsum's disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation.
    Wierzbicki AS; Lloyd MD; Schofield CJ; Feher MD; Gibberd FB
    J Neurochem; 2002 Mar; 80(5):727-35. PubMed ID: 11948235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phytanic acid alpha-oxidation. Differential subcellular localization in rat and human tissues and its inhibition by nycodenz.
    Singh I; Pahan K; Dhaunsi GS; Lazo O; Ozand P
    J Biol Chem; 1993 May; 268(14):9972-9. PubMed ID: 8486724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of Refsum's disease. Phytanic acid oxidase deficiency.
    Poulos A; Pollard AC; Mitchell JD; Wise G; Mortimer G
    Arch Dis Child; 1984 Mar; 59(3):222-9. PubMed ID: 6201142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological disorders and phytanic acid metabolism.
    Skjeldal OH; Nyberg-Hansen R; Stokke O
    Acta Neurol Scand; 1988 Oct; 78(4):324-8. PubMed ID: 3223227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisomal functions in classical Refsum's disease: comparison with the infantile form of Refsum's disease.
    Wanders RJ; Heymans HS; Schutgens RB; Poll-Thé BT; Saudubray JM; Tager JM; Schrakamp G; van den Bosch H
    J Neurol Sci; 1988 Apr; 84(2-3):147-55. PubMed ID: 2454298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phytanic acid alpha-oxidation: accumulation of 2-hydroxyphytanic acid and absence of 2-oxophytanic acid in plasma from patients with peroxisomal disorders.
    ten Brink HJ; Schor DS; Kok RM; Poll-The BT; Wanders RJ; Jakobs C
    J Lipid Res; 1992 Oct; 33(10):1449-57. PubMed ID: 1385561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation and defective beta-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants.
    Poulos A; Singh H; Paton B; Sharp P; Derwas N
    Clin Genet; 1986 May; 29(5):397-408. PubMed ID: 2427264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.